​

Cidara Therapeutics (CDTX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Cidara Therapeutics Revenue Highlights

Latest Revenue (Y)

$1.27M

0

Main Segment (Y)

Reportable Segment

Cidara Therapeutics Revenue by Period

Cidara Therapeutics Revenue by Year

DateRevenueChange
2024-12-31$1.27M-98.00%
2023-12-31$63.91M-0.60%
2022-12-31$64.29M29.69%
2021-12-31$49.57M310.81%
2020-12-31$12.07M-42.30%
2019-12-31$20.91M100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31--

Cidara Therapeutics generated $1.27M in revenue during NA 2024, up -98.00% compared to the previous quarter, and up 6.10% compared to the same period a year ago.

Cidara Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30--100.00%
2024-06-30$302.00K-96.43%
2024-03-31$8.46M-51.87%
2023-12-31$17.58M38.25%
2023-09-30$12.72M67.03%
2023-06-30$7.61M-70.70%
2023-03-31$25.99M154.33%
2022-12-31$10.22M-74.92%
2022-09-30$40.74M555.47%
2022-06-30$6.22M-12.56%
2022-03-31$7.11M-1.61%
2021-12-31$7.22M2.11%
2021-09-30$7.08M-78.47%
2021-06-30$32.86M1264.74%
2021-03-31$2.41M-35.43%
2020-12-31$3.73M54.35%
2020-09-30$2.42M-28.77%
2020-06-30$3.39M34.07%
2020-03-31$2.53M39.39%
2019-12-31$1.81M-90.50%
2019-09-30$19.10M100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31--

Cidara Therapeutics generated - in revenue during Q3 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Cidara Therapeutics Revenue Breakdown

Cidara Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24
Reportable Segment$1.27M

Cidara Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 24: Reportable Segment (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 23Jun 21Mar 21
Collaboration Revenue$7.61M$32.86M$2.41M

Cidara Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Jun 23: Collaboration Revenue (100.00%).

Cidara Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CTMXCytomX Therapeutics$138.10M$33.43M
CDTXCidara Therapeutics$1.27M-
GLYCGlycoMimetics--
CLSDClearside Biomedical-$1.04M

CDTX Revenue FAQ

What is Cidara Therapeutics’s yearly revenue?

Cidara Therapeutics's yearly revenue for 2024 was $1.28M, representing a decrease of -98.00% compared to 2023. The company's yearly revenue for 2023 was $63.9M, representing a decrease of -0.60% compared to 2022. CDTX's yearly revenue for 2022 was $64.29M, representing an increase of 29.69% compared to 2021.

What is Cidara Therapeutics’s quarterly revenue?

Cidara Therapeutics's quarterly revenue for Q3 2024 was $0, a -100.00% decrease from the previous quarter (Q2 2024), and a -100.00% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $302K, a -96.43% decrease from the previous quarter (Q1 2024), and a -96.03% decrease year-over-year (Q2 2023). CDTX's quarterly revenue for Q1 2024 was $8.46M, a -51.87% decrease from the previous quarter (Q4 2023), and a -67.44% decrease year-over-year (Q1 2023).

What is Cidara Therapeutics’s revenue growth rate?

Cidara Therapeutics's revenue growth rate for the last 3 years (2022-2024) was -98.02%, and for the last 5 years (2020-2024) was -89.43%.

What are Cidara Therapeutics’s revenue streams?

Cidara Therapeutics's revenue streams in c 24 are Reportable Segment

What is Cidara Therapeutics’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Cidara Therapeutics was Reportable Segment. This segment made a revenue of $1.28M, representing 100.00% of the company's total revenue.